IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 47 filers reported holding IBERE PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $514,540 | +1.9% | 50,995 | 0.0% | 0.00% | – |
| Q3 2022 | $505,000 | -8.0% | 50,995 | -8.9% | 0.00% | – |
| Q2 2022 | $549,000 | 0.0% | 55,995 | 0.0% | 0.00% | – |
| Q1 2022 | $549,000 | +1.3% | 55,995 | 0.0% | 0.00% | – |
| Q4 2021 | $542,000 | -0.2% | 55,995 | 0.0% | 0.00% | – |
| Q3 2021 | $543,000 | +2.5% | 55,995 | +2.3% | 0.00% | – |
| Q2 2021 | $530,000 | – | 54,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |